VERTEX PHARMACEUTICALS INC / MA ($VRTX)
Filing Information
| Accession Number | 0000875320-26-000080 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 19, 2026 |
| Document Date | Feb 17, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
4,602
Total Value
$1,353,579.56
P&L
+inf% (+$821,286.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP & Chief Accounting Officer | Common Stock | โ | Feb 17, 2026 | Grant/Award | 1,809 | $0.00 | $0.00 | 10,543 | Direct | โ | View Details | |
SVP & Chief Accounting Officer | Common Stock | โ | Feb 17, 2026 | Tax Withholding | 598 | $483.75 | $289,282.50 | 9,945 | Direct | โ | View Details | |
SVP & Chief Accounting Officer | Common Stock | โ | Feb 17, 2026 | Sale | 1,557 | $489.46 | $762,089.22 | 8,388 | Direct | โ | View Details | |
SVP & Chief Accounting Officer | Common Stock | โ | Feb 18, 2026 | Sale | 638 | $473.68 | $302,207.84 | 7,750 | Direct | โ | View Details |